WEHI has more than 300 research projects underway in cancer, immunology and infectious diseases, feeding into our discovery and development pipeline. We are committed to the translation of our discoveries into improvements in disease diagnosis, prevention and treatment.

Partnering opportunities now open

Opportunities in cancer

• Safer CAR-T cells
• High affinity dual-specificity biologics

Opportunities in immunology and inflammation

• pDC therapy for lupus
• Epigenetic inhibitor 
• Mucolytics

Opportunities in global health and infection

• VirDUB - targeting Mpro
• VirPRO - targeting PLPro
• C-FIND - rapid point of care diagnostic
• Toxoplasma vaccine
• Antihelminth therapy

Opportunities in neurological disorders

• Precision epigenetics
• Preventing cell loss in retinal disease
• Rare genetic disorders diagnostics

Opportunities in platform technologies

• IL-11 signaling
• E3 ligase warheads

Opportunities in digital health

• Genomic orchestration engine

Contact

To discuss partnering opportunities, please contact

Dr Anne-Laure Puaux
Head of Biotechnology and Commercialisation
Email partnering@wehi.edu.au.